Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseasesSeptember 24, 2026
General Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseasesBy Healthcare Propulsion StaffSeptember 24, 20260 Decades of work on RNA targeting, chemical modification, and tissue-specific delivery are reshaping what programmable genetic medicines can treat and…